Velázquez-Quesada I, Ruiz-Moreno AJ, Casique-Aguirre D, Aguirre-Alvarado C, Cortés-Mendoza F, de la Fuente-Granada M, . . . Velasco-Velázquez MA. (2020). Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells. Dove Medical Press.
Chicago Style (17th ed.) CitationVelázquez-Quesada I, et al. Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells. Dove Medical Press, 2020.
MLA (9th ed.) CitationVelázquez-Quesada I, et al. Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells. Dove Medical Press, 2020.
Warning: These citations may not always be 100% accurate.